TECH Financials

Income Statement
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025
Revenue
321.2M
+3.1%
311.4M
+5.3%
295.9M
+3.3%
286.6M
-9.6%
317.0M
Cost of Revenue
109.8M
+6.5%
103.1M
-1.4%
104.6M
+6.3%
98.4M
-16.7%
118.2M
Gross Profit
211.4M
+1.5%
208.3M
+8.9%
191.3M
+1.7%
188.1M
-5.4%
198.8M
Operating Expenses
137.1M
+3.3%
132.8M
-2.9%
136.8M
-2.6%
140.5M
-36.9%
222.7M
R&D
23.9M
+2.1%
23.5M
+1.4%
23.1M
-4.6%
24.2M
-6.9%
26.0M
SG&A
113.2M
+3.5%
109.3M
-3.8%
113.7M
-2.2%
116.2M
-40.9%
196.6M
Operating Income
74.3M
-1.6%
75.5M
+38.6%
54.5M
+14.3%
47.7M
+299.7%
-23860000
EBITDA
98.4M
-1.3%
99.7M
+25.9%
79.2M
+10.0%
72.0M
+2114.6%
3.3M
Net Income
54.6M
+7.0%
51.0M
+34.3%
38.0M
-0.5%
38.2M
+316.0%
-17678000
EPS (Basic)
$0.35
+6.1%
$0.33
+37.5%
$0.24
-4.0%
$0.25
+327.3%
$-0.11
EPS (Diluted)
$0.35
+9.4%
$0.32
+33.3%
$0.24
+0.0%
$0.24
+318.2%
$-0.11
Shares (Diluted)
157.3M
-0.1%
157.4M
+0.3%
157.0M
+0.4%
156.4M
-1.2%
158.2M
Bio-Techne (TECH) โ€” Financials